05 Aug - 2 min read

Changes to the Board – Appointment of Sean Capazorio as Executive Director and Group Chief Financial Officer

Changes to the Board – Appointment of Sean Capazorio as Executive Director and Group Chief Financial Officer

ASPEN PHARMACARE HOLDINGS LIMITED
(Incorporated in the Republic of South Africa) (“Aspen Holdings”)
Registration number: 1985/002935/06
Share code: APN
ISIN: ZAE000066692
LEI: 635400ZYSN1IRD5QWQ94
and its subsidiaries (collectively “Aspen” or “the Group”)



CHANGES TO THE BOARD – APPOINTMENT OF SEAN CAPAZORIO AS EXECUTIVE DIRECTOR AND GROUP
CHIEF FINANCIAL OFFICER WITH EFFECT FROM 1 JANUARY 2022

Shareholders are referred to the announcement on 10 February 2021 wherein Gus Attridge’s intention to
step down from his current role as Deputy Group Chief Executive and as the Finance Director of Aspen,
with effect from the end of this year, was confirmed.

In accordance with paragraph 3.59 of the Listings Requirements of the JSE, the Aspen Board of Directors
(“the Board”) is pleased to announce, following a process of evaluating internal and external candidates,
that Mr Sean Capazorio has been appointed to become the Group Chief Financial Officer, and
consequently, will be appointed to become an executive director of the Board, with effect from 1 January
2022. Sean will fulfil the prescribed function of executive financial director from this date, in terms of
paragraph 3.84(f) of the Listings Requirements.

Sean is a Chartered Accountant (SA) and holds an Advanced Certificate in Taxation (UNISA). He joined the
Group as an employee of the South African Druggist’s pharmaceutical business which was acquired by
Aspen in 1999 and has held the position of Group Finance Officer since 2009. The Board has expressed its
confidence in Sean’s financial skills, technical expertise and deep corporate knowledge of the Group. Sean
has earned the respect of his colleagues throughout the Group and it is believed that the continuity he will
bring to the position will ensure a smooth handover of the role’s responsibilities to him.

As also confirmed in the announcement of 10 February 2021, Gus will remain available to the Group in a
new role which will, amongst other duties, include supporting and mentoring the executive team.

The Board extends its congratulations to Sean on his appointment and wishes him every success in this
role.



Durban
05 August 2021

Sponsor
Investec Bank Limited

Date: 05-08-2021 08:00:00
Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Aspen Pharmacare Holdings Limited (JSE:APN) when you join Listcorp.